GLOBEALERT
BUSINESS● LOWAug 12 · Aug 12, 2026, 12:32 PM

Aprea Therapeutics GAAP EPS of -$0.07 beats by $0.16

Seeking Alpha Tech

Aprea Therapeutics reported GAAP earnings per share of -$0.07, which surpassed analyst expectations. This indicates the company's financial performance relative to forecasts.

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

More in Business